Literature DB >> 28028624

Intravenous thrombolysis of stroke in early pregnancy: a case report and review of the literature.

Alice Reining-Festa1, Daniela Földy2, Margarethe Coulibaly-Wimmer3, Lisbeth Eischer4, Maria Heger5, Elisabeth Fertl2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28028624     DOI： 10.1007/s00415-016-8369-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Fibrinolysis with alteplase in a pregnant woman with stroke.

Authors:  Michael Dapprich; Wolfgang Boessenecker
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

Review 2.  [Intravenous recombinant tissue plasminogen activator in an 18-week pregnant woman with embolic stroke].

Authors:  Yuko Yamaguchi; Takayuki Kondo; Masafumi Ihara; Jun Kawamata; Hidenao Fukuyama; Ryosuke Takahashi
Journal:  Rinsho Shinkeigaku       Date:  2010-05

3.  Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke.

Authors:  Kathleen M Wiese; Arun Talkad; Maureen Mathews; David Wang
Journal:  Stroke       Date:  2006-06-22       Impact factor: 7.914

4.  Systemic thrombolysis for stroke in pregnancy.

Authors:  Rossana Tassi; Maurizio Acampa; Giovanna Marotta; Samuele Cioni; Francesca Guideri; Simone Rossi; Alfonso Cerase; Giuseppe Martini
Journal:  Am J Emerg Med       Date:  2012-08-04       Impact factor: 2.469

5.  Yes, intravenous thrombolysis should be administered in pregnancy when other clinical and imaging factors are favorable.

Authors:  Andrew M Demchuk
Journal:  Stroke       Date:  2013-02-07       Impact factor: 7.914

6.  Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy.

Authors:  Laura Mantoan Ritter; A Schüler; R Gangopadhyay; L Mordecai; O Arowele; N Losseff; P O' Brien; B Dewan
Journal:  J Neurol       Date:  2014-02-26       Impact factor: 4.849

Review 7.  Stroke and pregnancy.

Authors:  C A Davie; P O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-11-06       Impact factor: 10.154

8.  [Intravenous recombinant tissue plasminogen activator therapy in a 14-week pregnant woman with embolic stroke due to protein S deficiency].

Authors:  Hiroko Hori; Fumio Yamamoto; Yasuyuki Ito; Yoichiro Hashimoto; Teruyuki Hirano; Makoto Uchino
Journal:  Rinsho Shinkeigaku       Date:  2013

9.  Thrombolysis for stroke in pregnancy at 39 weeks gestation with a subsequent normal delivery.

Authors:  Joanne Ritchie; Mariam Lokman; Jane Panikkar
Journal:  BMJ Case Rep       Date:  2015-08-11

Review 10.  Neuroendocrinal, Neurodevelopmental, and Embryotoxic Effects of Recombinant Tissue Plasminogen Activator Treatment for Pregnant Women with Acute Ischemic Stroke.

Authors:  Anna Steinberg; Tiago P Moreira
Journal:  Front Neurosci       Date:  2016-02-25       Impact factor: 4.677
View more
  4 in total

Review 1.  Stroke in Pregnancy: A Focused Update.

Authors:  Eliza C Miller; Lisa Leffert
Journal:  Anesth Analg       Date:  2020-04       Impact factor: 5.108

2.  European Stroke Organisation guidelines on stroke in women: Management of menopause, pregnancy and postpartum.

Authors:  Christine Kremer; Zuzana Gdovinova; Yannick Bejot; Mirjam R Heldner; Susanna Zuurbier; Silke Walter; Avtar Lal; Corina Epple; Svetlana Lorenzano; Marie-Luise Mono; Theodore Karapanayiotides; Kailash Krishnan; Dejana Jovanovic; Jesse Dawson; Valeria Caso
Journal:  Eur Stroke J       Date:  2022-03-29

Review 3.  Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.

Authors:  Hannah J Roeder; Jean Rodriguez Lopez; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020

4.  Combined reperfusion therapy to treat cryptogenic acute ischemic stroke during the first trimester of pregnancy: case report and literature review.

Authors:  François Zhu; Benjamin Gory; Gioia Mione; Lisa Humbertjean; Anne-Laure Derelle; Sébastien Richard
Journal:  Ther Clin Risk Manag       Date:  2018-09-11       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.